RE: RE: What is stopping GW.... Chief...simple question:
If GW, with their proposed BOD, had taken over the company 3 weeks ago and put out a letter to shareholders that indicated they had 30 "approaches" for a Urocidin partnership, with two proposals tabled, as well as 3 offers for Animal Health, would the SP be at 33 cents? Would we be under $1.00? Would we be under $1.50? Would we be under $2.00?
That is really the only question that needs to be answered.
If you think that the company would still be valued at 1 year's revenue with the P3 Urocidin trial data and VMC free of charge, you should support the status quo.